Patrick D. Mauldin, PhD

home / authors / patrick-d-mauldin-phd

Articles

September 1st 1999

The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I

Edmund R. Becker, PhD Douglas C. Morris, MD Steven D. Culler, PhD Patrick D. Mauldin, PhD Leslee J. Shaw, PhD J. David Talley, MD Will

September 1st 1999

The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II

Edmund R. Becker, PhD Douglas C. Morris, MD Steven D. Culler, PhD Patrick D. Mauldin, PhD Leslee J. Shaw, PhD J. David Talley, MD Will

May 1st 1997

Economic Winners and Losers After Introduction of an Effective New Therapy Depend on the Type of Payment System

William S. Weintraub, MD Christi D. Warner, PhD Patrick D. Mauldin, PhD Edmund R. Becker, PhD Daniel Gomes, MPH John Cook, PhD Andrzej

December 1st 1996

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

William S. Weintraub, MD Patrick D. Mauldin, PhD J. David Talley, MD George A. Diamond, MD John Merlino, MD Joseph Lindsay, MD Monty M. Bodenheimer, MD Samuel DeMaio, MD Lloyd W. Klein, MD Da

October 1st 1996

The Influence of New Devices on the Costs of Interventional Procedures

William S. Weintraub, MD Ron Waksman, MD Jim Benard, RN, MS Edmund R. Becker, PhD Patrick D. Mauldin, PhD Ziyad M. B. Ghazzal, MD John

September 1st 1996

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

William S. Weintraub, MD Patrick D. Mauldin, PhD J. David Talley, MD George A. Diamond, MD John Merline, MD Joseph Lindsay, MD Monty M

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions